(Q37105364)

English

Expression of the h19 oncofetal gene in premalignant lesions of cervical cancer: a potential targeting approach for development of nonsurgical treatment of high-risk lesions

scientific article published on 31 July 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Expression of the h19 oncofetal gene in premalignant lesions of cervical cancer: a potential targeting approach for development of nonsurgical treatment of high-risk lesions (English)

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

author name string

Tomer Feigenberg

1

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Ofer N Gofrit

2

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Galina Pizov

3

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Avraham Hochberg

4

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Abraham Benshushan

5

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

publication date

31 July 2013

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

ISRN Obstetrics & Gynecology

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

2013

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

137509

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

copyright license

Creative Commons Attribution 3.0 Unported

31 July 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

Development of targeted therapy for ovarian cancer mediated by a plasmid expressing diphtheria toxin under the control of H19 regulatory sequences

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747480

14 September 2017

Human papillomavirus and molecular considerations for cancer risk

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747480

14 September 2017

Phase I/II marker lesion study of intravesical BC-819 DNA plasmid in H19 over expressing superficial bladder cancer refractory to bacillus Calmette-Guerin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747480

14 September 2017

The H19 non-coding RNA is essential for human tumor growth

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747480

14 September 2017

Organization of human papillomavirus productive cycle during neoplastic progression provides a basis for selection of diagnostic markers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747480

14 September 2017

Possible physiological role of H19 RNA

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747480

14 September 2017

The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747480

14 September 2017

The non-coding RNAs as riboregulators

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747480

14 September 2017

Imprinted H19 oncofetal RNA is a candidate tumour marker for hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747480

14 September 2017

The imprinted H19 gene as a tumor marker in bladder carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747480

14 September 2017

Disruption of imprinting caused by deletion of the H19 gene region in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747480

14 September 2017

Recombinant toxins as novel therapeutic agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747480

14 September 2017

Inhibition of tumor growth by DT-A expressed under the control of IGF2 P3 and P4 promoter sequences

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747480

29 September 2017

Genetic ablation: targeted expression of a toxin gene causes microphthalmia in transgenic mice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747480

27 June 2018

Alterations in promoter usage and expression levels of insulin-like growth factor-II and H19 genes in cervical carcinoma exhibiting biallelic expression of IGF-II.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747480

3 September 2018

Use of H19 regulatory sequences for targeted gene therapy in cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747480

3 September 2018

H19 gene expression is up-regulated exclusively by stabilization of the RNA during muscle cell differentiation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747480

3 September 2018

Regulatory sequences of H19 and IGF2 genes in DNA-based therapy of colorectal rat liver metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/23984081

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gain of the 3q26 region in cervicovaginal liquid-based pap preparations is associated with squamous intraepithelial lesions and squamous cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23984081

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2

1 reference

https://pubmed.ncbi.nlm.nih.gov/23984081

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High incidence of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinomas. Uncoupling of H19 and IGF2 expression and biallelic hypomethylation of H19

1 reference

https://pubmed.ncbi.nlm.nih.gov/23984081

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The expression of the imprinted genes H19 and IGF-2 in choriocarcinoma cell lines. Is H19 a tumor suppressor gene?

1 reference

https://pubmed.ncbi.nlm.nih.gov/23984081

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1155/2013/137509

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37105364&oldid=2169212390"